Clinical Trial Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial stocks.

Clinical Trial Stocks Recent News

Date Stock Title
Oct 4 EXAI Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains?
Oct 3 VRCA Verrica downgraded to hold by Needham, cash position cited
Oct 3 VRCA This Tractor Supply Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Oct 2 LQDA Liquidia expands licensing deal with Pharmosa for lung therapy
Oct 2 STTK Top Midday Decliners
Oct 2 STTK Shattuck Labs stock craters following pipeline and job cuts
Oct 2 STTK Shattuck cut to Neutral at Citi on program exit
Oct 2 STTK STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
Oct 2 VRCA Verrica Pharmaceuticals reports restructuring of commercial organization
Oct 2 EXAI Exscientia outline robot and AI use in drug discovery workflow
Oct 2 VRCA Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
Oct 2 STTK Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts
Oct 2 LQDA Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
Oct 1 STTK Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline
Oct 1 STTK Shattuck plunges after discontinuing lead candidate
Oct 1 STTK Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway
Sep 30 LQDA Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
Sep 29 VRCA Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now
Clinical Trial

A clinical trial is a research study in which people volunteer to test new treatments, interventions, or tests as a means to prevent, detect, or treat diseases or conditions. Clinical trials are conducted to determine the safety and effectiveness of new drugs, medical devices, or other treatments.

Browse All Tags